Advertisement Fidelity
Home > Boards > US Listed > Medical - Equipment > Navidea Biopharmaceuticals, Inc. (NAVB)

$120 per share for NAVB? Let the

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
casperboo Member Profile
 
Followed By 5
Posts 914
Boards Moderated 1
Alias Born 02/13/10
160x600 placeholder
Navidea Biopharmaceuticals Provides Progress Updates on Lymphoseek® Programs "Business Wire" - 4/17/2014 5:30:00 PM
Navidea Pharmaceuticals Inc. Analyst Report: Long Term Market Potential of Lymphoseek does not Justify Current Valuation by ... "PR Newswire (US)" - 4/11/2014 7:00:00 AM
Navidea Announces Presentation of Study Findings of Manocept™ Platform Imaging Agent in Kaposi Sarcoma at AACR Annual Meeting "Business Wire" - 4/10/2014 7:30:00 AM
Navidea Announces Presentations Highlighting NAV4694 Beta-Amyloid, PET Imaging Agent at the German Society of Nuclear Medicin... "Business Wire" - 3/26/2014 7:30:00 AM
Navidea Biopharmaceuticals Provides Update on European Marketing Authorization Application for Lymphoseek® "Business Wire" - 3/19/2014 5:30:00 PM
Annual Report (10-k) "Edgar (US Regulatory)" - 3/14/2014 5:00:28 PM
Navidea Biopharmaceuticals Announces Presentation of Lymphoseek® Three-Year Recurrence & Survival Outcomes after Sentinel Ly... "Business Wire" - 3/14/2014 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/11/2014 5:21:52 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/11/2014 5:21:52 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/11/2014 5:21:52 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/11/2014 5:14:04 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/7/2014 4:39:26 PM
Navidea Announces Fourth Quarter and Full Year 2013 Results "Business Wire" - 3/6/2014 7:30:00 AM
Navidea Biopharmaceuticals Closes $30 Million Loan with Oxford Finance, LLC "Business Wire" - 3/6/2014 7:00:00 AM
Navidea Announces Acceptance for Review of an Additional sNDA to Further Expand Lymphoseek® Labeling "Business Wire" - 3/5/2014 7:30:00 AM
Navidea Biopharmaceuticals to Announce Fourth Quarter and Full-Year 2013 Financial Results on Thursday, March 6, 2014 "Business Wire" - 3/3/2014 2:18:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/19/2014 11:08:56 AM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 2/19/2014 11:05:46 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/19/2014 9:21:47 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/18/2014 4:55:22 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/18/2014 4:55:22 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/18/2014 4:55:22 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/18/2014 4:55:22 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/18/2014 4:55:22 PM
U.S. Hot Stocks: Hot Stocks to Watch "Dow Jones News" - 2/18/2014 9:18:21 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist